Published in Immunology on June 01, 1975
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38
Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol (1972) 4.04
Cellular immunity against tumor antigens. Adv Cancer Res (1969) 3.70
The influence of polyvalency on the binding properties of antibodies. Immunochemistry (1972) 2.67
The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata. Br J Cancer (1973) 1.83
Biochemical and biological characteristics of lymphocyte surface immunoglobulin. Transplant Rev (1973) 1.50
Receptors on immunocompetent cells. IV. Direct measurement of avidity of cell receptors and cooperative binding of multivalent ligands. J Exp Med (1972) 1.38
The immune response against hapten-autologous protein conjugates in the mouse. I. Specificity of antibodies produced during the primary response against dinitrophenylated mouse serum albumin. Eur J Immunol (1973) 1.27
Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum. Br J Cancer (1973) 1.17
Microfluorometry on antigen-antibody interaction in immunofluorescence using antigens covalently bound to agarose beads. J Immunol Methods (1973) 1.17
Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy. Br J Cancer (1973) 1.11
Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates. J Exp Med (1973) 1.00
Antibody-mediated suppression of the immune response in vitro. IV. The effect of antibody fragments. J Immunol (1972) 0.88
Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Loss of Gastro-intestinal-specific Antigen in Neoplasia. Br Med J (1962) 2.59
Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer (1978) 2.48
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Anti-tumor immunoreactivity in patients with malignant melanoma. Med J Aust (1972) 2.05
Standardization in immunofluorescence. Clin Exp Immunol (1968) 2.01
Kidney-specific antigen depletion in human renal carcinomas. Br J Cancer (1966) 1.89
Immunological reactivity in patients with carcinoma of colon. Br Med J (1971) 1.80
Immunofluorescent staining of rat gastric parietal cells by human antibody unrelated to pernicious anaemia. J Clin Pathol (1971) 1.79
Production of an anti-tumour cytotoxin by human monocytes. Immunology (1981) 1.78
Serological diagnosis of amoebiasis by immunofluorescence. J Clin Pathol (1967) 1.67
Species distribution of gastrointestinal antigens. Nature (1966) 1.62
Autoantibodies in ulcerative colitis. Br Med J (1967) 1.55
Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system. Br J Cancer (1976) 1.53
Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization. Br J Cancer (1980) 1.47
Specific immune response in human skin carcinoma. Br Med J (1971) 1.44
Origin and fate of a thymocyte-specific antigen. Immunology (1967) 1.41
Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg (1991) 1.40
Lymphocyte anergy in patients with carcinoma. Br J Cancer (1973) 1.38
Renal tubular antigens in kidney tumors. Cancer (1972) 1.37
Specific antigenicity of thymocytes. Nature (1967) 1.35
Self-efficacy for coping with cancer: revision of the Cancer Behavior Inventory (version 2.0). Psychooncology (2001) 1.35
Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. Br J Cancer (1979) 1.35
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers. Br J Cancer (1982) 1.28
Microphotometry in immunofluorescence. Clin Exp Immunol (1969) 1.24
Tumour-necrosis factor from the rabbit. III. Relationship to interferons. Br J Cancer (1979) 1.23
Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology (1988) 1.17
Neutral amino acid uptake by the microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy. J Clin Endocrinol Metab (1998) 1.15
Extraction of gastric parietal cell autoantigen. Clin Exp Immunol (1967) 1.14
Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br J Cancer (1981) 1.13
Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12
Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy. Br J Cancer (1973) 1.11
Plasma proteins in the glomerular lesions of NZB/NZW mice. Br J Exp Pathol (1966) 1.08
Incidence of autoantibodies in cancer patients. Clin Exp Immunol (1973) 1.08
Immunoradioactive agent against cancer. Br Med J (1967) 1.07
Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin. Immunology (1983) 1.07
Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Br J Cancer (1975) 1.07
Lymphoid hyperplasia: a major prognostic feature in 519 cases of colorectal carcinoma. Am J Pathol (1980) 1.07
Gastric parietal cell autoantigen. Physical, chemical and biological properties. Clin Exp Immunol (1972) 1.06
Lymphoid-specific antigen: distribution and behaviour. Immunology (1968) 1.06
Immunogenicity of lipid-conjugated antigens. II. Anti-complementary activity and antigen trapping in the spleen. Immunology (1980) 1.04
pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem (1999) 1.01
Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma. Cancer Res (1976) 1.00
Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade. Br J Cancer (1973) 1.00
Gastric antigens in health and disease. Behaviour in early development, senescence, metaplasia, and cancer. Br Med J (1969) 0.99
Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action. Br J Cancer (1983) 0.99
Mucinous colorectal carcinoma: immunopathology and prognosis. Pathology (1980) 0.97
A study of cell mediated and humoral immunity in haemophilia and related disorders. Br J Haematol (1985) 0.97
A case of hereditary combined deficiency of complement components C6 and C7 in man. Clin Exp Immunol (1989) 0.97
Human growth hormone in cultures of human pituitary tumors. J Neurosurg (1971) 0.97
Assay of anti-lymphocyte serum by membrane immunofluorescence. J Immunol Methods (1971) 0.97
Coeliac disease associated with auto-immune thyroiditis, Sjogren's syndrome, and a lymphocytotoxic serum factor. Aust N Z J Med (1972) 0.97
Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol (1989) 0.95
Partial mechanization of membrane immunofluorescent staining techniques. Clin Exp Immunol (1971) 0.95
Fluorescent probes to detect lymphocyte activation. Clin Exp Immunol (1980) 0.95
Smoking, humoral immunity, and ulcerative colitis. Gut (1991) 0.95
Zymosan-induced leukotriene B4 generation by human neutrophils is augmented by rhTNF-alpha but not chemotactic peptide. Immunology (1990) 0.94
Tumour cells which develop resistance to cytolysis by tumour necrosis factor have a different glycoform of a 105-kDa glycoprotein and lose the capacity to invade and metastasize. Int J Cancer (1990) 0.94
Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement. Clin Exp Immunol (1980) 0.94
Lymphoid cell fractionation by aggregated immunoglobulin-agarose columns. J Immunol Methods (1976) 0.94
Immunohistological patterns of carcinoembryonic antigen in colorectal carcinoma. Correlation with staging and blood levels. Pathology (1980) 0.94
A nuclear staining artefact in immunofluorescence. Clin Exp Immunol (1967) 0.91
Electron microscope observations of the in vitro interaction between human leucocytes and cancer cells. Aust J Exp Biol Med Sci (1974) 0.90
Persistence of gastrointestinal-specific antigens in primary culture of human colon epithelium. Exp Cell Res (1968) 0.90
"Spontaneous" cytolysis by normal human lymphocytes of Burkitt's lymphoma cells of the EB2 cell line. Aust J Exp Biol Med Sci (1974) 0.90
Fetuin: an acute phase protein in cattle. J Comp Physiol B (1992) 0.90
Autoimmunity to collagen in adult periodontal disease: immunoglobulin classes in sera and tissue. J Periodontal Res (1992) 0.90
Anti-tumour immunoreactivity in colonic carcinoma. A guide to early recognition of recurrence. Aust N Z J Med (1974) 0.89
Intestinal antigenicity of ovarian mucinous cystadenomas. Br J Cancer (1971) 0.88
Production of hemopoietic growth factors and gamma-interferon by large granular lymphocytes from patients with T gamma lymphocytosis. Int J Cell Cloning (1987) 0.88
Antibodies to influenza A in a cluster of children with juvenile chronic arthritis. Br J Rheumatol (1988) 0.88
Human monocyte killing of tumor cells: contribution of an extracellular cytotoxin. Adv Exp Med Biol (1982) 0.88
Effect of serine/threonine kinase inhibitors on motility of human lymphocytes and U937 cells. Immunology (1994) 0.88
A simple, sensitive and reproducible assay for pyridoxal 5'-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta (1999) 0.87
Cardiovascular and pulmonary function studies of a new sedative/analgetic (detomidine/Domosedan) for use alone in horses or as a preanesthetic. Acta Vet Scand Suppl (1986) 0.87
Characterisation of a new tryptic sub-fragment of human and rabbit IgG Fc fragment. Immunochemistry (1971) 0.86
Another oncofoetal antigen in colonic carcinoma. Br J Cancer (1980) 0.86
Regional lymph node and stromal immunomorphology in colorectal carcinoma and relation to tumour spread. Pathology (1980) 0.85
Inhibition of protein kinase C results in a switch from a non-motile to a motile phenotype in diverse human lymphocyte populations. Immunology (1995) 0.85
Chemical synthesis, expression and product assessment of a gene coding for biologically active human tumour necrosis factor alpha. Protein Eng (1989) 0.85
Differential augmentation by recombinant human tumor necrosis factor-alpha of neutrophil responses to particulate zymosan and glucan. J Immunol (1990) 0.85
Subcellular localization of Entamoeba histolytica antigen. Nature (1967) 0.85
Acridine orange fluorescence cytochemistry for detecting lymphocyte immunoreactivity. J Immunol Methods (1976) 0.85
Conditions for purification of anti-Brucella antibodies by immunoadsorption and elution. Immunochemistry (1974) 0.85
Expression of the tumor-associated mucin MUC1 in an ovarian tumor cell line. Int J Cancer (1992) 0.85
Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells. Br J Rheumatol (1996) 0.84
Distribution of nephric antigens in Australian vertebrates. Nature (1967) 0.84
Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells--analysis of tumour necrosis factor-receptor interactions. Cytokine (1992) 0.84
Criteria of cell killing in vitro. J Immunol Methods (1981) 0.83
Chlamydia and Crohn's disease. Lancet (1979) 0.83
Lymphoreticular response to a syngeneic rat tumour: gravimetric and histological studies. Br J Cancer (1975) 0.83
alpha 2HS-glycoprotein is expressed at high concentration in human fetal plasma and cerebrospinal fluid. Fetal Diagn Ther (1993) 0.82
Heterologous antiserum against gastric parietal cells induced by sub-microsomal gastric mucosal fraction. Clin Exp Immunol (1971) 0.82